MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 5, 2007; DOI: 10.1124/mol.107.036541


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.036541v1
72/3/695    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CHIU, Y.-C.
Right arrow Articles by Tang, C.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHIU, Y.-C.
Right arrow Articles by Tang, C.-H.


Received for publication March 29, 2007.
Revised June 3, 2007.
Accepted for publication June 4, 2007.

Stromal cell-derived factor-1 induces matrix metalloprotease-13 expression in human chondrocytes

YUNG-CHENG CHIU 1, RONG-SEN YANG 2, KWO-HSIEN HSIEH 3, YI-CHIN FONG 4, TZONG-DER WAY 5, TU-SHENG LEE 1, HSI-CHIN WU 5, WEN-MEI FU 6, Chih-Hsin Tang 5*

1 Taichung Veterans General Hospital 2 National Taiwan University & Hospital 3 Tung's Taichung MetroHarbor Hospital 4 China Medical University Hospital 5 China Medical University 6 National Taiwan University

* Address correspondence to: E-mail: chtang{at}mail.cmu.edu.tw

Abstract

The chemokine stromal cell-derived factor-1 (SDF-1) is significantly higher in synovial fluid of patients with osteoarthritis and rheumatoid arthritis. Matrix metalloproteinases (MMP)-13 may contribute to the breakdown of articular cartilage during arthritis. Here we found that SDF-1{alpha} increased the secretion of MMP-13 in cultured human chondrocytes, as shown by reverse transcriptase-polymerase chain reaction, Western blot and zymographic analysis. SDF-1{alpha} also increased the surface expression of CXCR4 receptor in human chondrocytes. CXCR4-neutralizing antibody, CXCR4 specific inhibitor (AMD3100) or small interfering RNA against CXCR4 inhibited the SDF-1{alpha}-induced increase of MMP-13 expression. The transcriptional regulation of MMP-13 by SDF-1{alpha} was mediated by phosphorylation of exracelluar signal-regulated kinases (ERK) and activation of the AP-1 components of c-Fos and c-Jun. The binding of c-Fos and c-Jun to the AP-1 element on the MMP-13 promoter and the increase of luciferase activity was enhanced by SDF-1{alpha}. Cotransfection with dominant-negative mutant of ERK2 or c-Fos and c-Jun antisense oligonucleotide inhibited the potentiating action of SDF-1{alpha} on MMP-13 promoter activity. Taken together, our results provide evidence that SDF-1{alpha} acts through CXCR4 to activate ERK, and the downstream transcription factors (c-Fos and c-Jun), resulting in the activation of AP-1 on the MMP-13 promoter and contribute cartilage destruction during arthritis.


Key words: MAP Kinase, Jun Kinase, AP-1





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics